|Videos|October 12, 2021

Addressing Influenza in the COVID-19 Era

Author(s)Tina Q. Tan, M.D., FAAP, FIDSA, FDIPS, John J Russell, MD, FAAFP, Stephan Foster, PharmD, FAPhA, FNAP

A group of experts led by Tina Q. Tan, MD, FAAP, FIDSA, FDIPS, discuss how best to address influenza prevention, identification, and treatment in the COVID-19 era and beyond.

Stay informed with the Medical Economics eNewsletter, delivering expert insights, financial strategies, practice management tips, and technology trends tailored for today’s physicians.

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Addressing Influenza in the COVID-19 Era

Related Content

Practice size: How many doctors are in the office?

Maternal mortality; brain implant research; $30M in phony claims for COVID-19 tests – Morning Medical Update

More than 90% of docs feeling burned out: survey

Doctors must have robust online presence to meet today’s patients’ expectations

Responding to patient requests for a second opinion

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Medical Economics

U.S. health care affordability hits a five-year low

Medicare’s 2027 Physician Fee Schedule: Will primary care finally be paid for what it actually does?

FDA clears BlueWind Medical's Revi Extend implant, extending device life to 15 years

Insurance was never meant to be a first-dollar payer, with Joanne Frederick

AI can reduce wasteful spending in Medicare — but WISeR isn't the answer